InteRNA Technologies BV - Company Review
InteRNA Technologies BV - Company ReviewSummary
InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing miRNA-based therapeutics which controls genes connected in signal transduction pathways. InteRNA’s technologies comprise deep sequencing and bioinformatics, miRNA expression database, data analyses platform, and lentiviral-based miRNA overexpression library. The company specializes in oncology programs including in vivo proof of concept for non-formulated anti-miRNA mimics, demonstrating significant tumor suppression in a mouse tumor xenograft model and development of a miRNA compound for mutant B-Raf associated solid tumors. InteRNA is headquartered in Nijmegen, the Netherlands.
This comprehensive company report of InteRNA Technologies BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.